1. Home
  2. AMBO vs APM Comparison

AMBO vs APM Comparison

Compare AMBO & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

HOLD

Current Price

$2.30

Market Cap

6.5M

Sector

Real Estate

ML Signal

HOLD

Logo Aptorum Group Limited

APM

Aptorum Group Limited

HOLD

Current Price

$0.87

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBO
APM
Founded
2000
2010
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
7.3M
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
AMBO
APM
Price
$2.30
$0.87
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.5K
22.8K
Earning Date
08-05-2025
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
337.04
N/A
EPS
0.02
N/A
Revenue
$9,469,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$89.41
N/A
Revenue Growth
0.82
N/A
52 Week Low
$1.47
$0.65
52 Week High
$6.75
$4.47

Technical Indicators

Market Signals
Indicator
AMBO
APM
Relative Strength Index (RSI) 49.02 46.49
Support Level $1.88 $0.75
Resistance Level $2.50 $0.86
Average True Range (ATR) 0.20 0.06
MACD -0.03 -0.00
Stochastic Oscillator 51.32 16.63

Price Performance

Historical Comparison
AMBO
APM

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Aptorum's project pipeline includes SACT-1, a repurposed drug for the treatment of neuroblastoma, and ALS-4, a small molecule for the treatment of bacterial infections caused by Staphylococcus aureus, including but not limited to Methicillin-resistant Staphylococcus aureus (MRSA). Substantially all of the company's revenues are derived from within Hong Kong.

Share on Social Networks: